Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PRA Expands Global Early Development Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

PRA Expands Global Early Development Services

Enhances capabilities and services in UT, NJ, KS and Russia

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PRA Health Sciences (PRA) is expanding its Early Development Services (EDS) by enhancing its global Phase I patient strategy and increasing its clinical footprint. The company will open an 11,000 sq.-ft. outpatient facility at its Salt Lake City, UT site, focusing on psychiatry, neurology, pain and other therapeutic areas. The new facility includes a dedicated pharmacy, clinical lab and surgical suites.
 
PRA is enhancing patient capabilities and service offerings by implementing operational site models at its Marlton, NJ facility similar to those used at its Patient Pharmacology Services operations in Central and Eastern Europe.
 
The company will also expand its Patient Pharmacology Services into Russia. The first clinical trial application was recently submitted for a rheumatoid arthritis patient study with approval expected in April.
 
Additionally, PRA is expanding its Human Abuse Liability (HAL) study capabilities at its Lenexa, KS site for the conduct of these specialized trials in more than one clinical pharmacology unit.
 
“With PRA conducting more than half of its Phase I/IIa studies in patients vs. volunteers, these initiatives will further enhance our U.S. patient capabilities and service offerings,” said Randall Hein, senior vice president, Clinical Research Services.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics